JAM2
JAM2 (junctional adhesion molecule 2, also known as JAM-B, VE-JAM and CD322) is a type I membrane protein of the immunoglobulin superfamily. It mediates cell-cell adhesion at junctions and acts as the cognate receptor partner of JAM3. Browse Assay Genie's current range of JAM2 research reagents below, or read on for the biology behind the target.
JAM2 is a junctional adhesion protein that mediates heterotypic cell-cell interactions with its cognate receptor JAM3, thereby regulating a range of cellular processes. In the bone marrow, JAM2 on stromal cells contributes to the retention of haematopoietic stem and progenitor cells that express JAM3, and it has a role in their homing and mobilisation. JAM2 also plays a central role in leukocyte extravasation, facilitating transmigration as well as tethering and rolling of leukocytes along the endothelium. Tethering and rolling depend on JAM2 binding the integrin alpha-4/beta-1.
The JAM2 gene encodes a type I membrane protein of the immunoglobulin superfamily and the JAM family. The protein localises to the tight junctions of both epithelial and endothelial cells, and it acts as an adhesive ligand for several immune cell types. It may contribute to lymphocyte homing to secondary lymphoid organs. Alternatively spliced transcript variants have been reported for the gene. The mouse ortholog is Jam2.
Beyond the immune system, JAM2 has roles in other tissues. In spermatogenesis, JAM2 on Sertoli cells and JAM3 on germ cells mediate an interaction that anchors germ cells to Sertoli cells and supports the assembly of cell polarity complexes during spermatid differentiation. JAM2 also acts as an inhibitory somatodendritic cue that prevents myelination of the non-axonal parts of neurons, and it is involved in myocyte fusion during myogenesis. It may also play a role in angiogenesis. The protein is also listed as CD322, JAM-2 and C21orf43, and researchers studying the JAM2 gene or JAM2 protein will meet these names in the literature.
JAM2 supports tethering, rolling and transmigration of leukocytes along the endothelium, partly through binding integrin alpha-4/beta-1.
JAM2 on bone marrow stromal cells helps retain JAM3-expressing haematopoietic stem and progenitor cells, influencing homing and mobilisation.
JAM2 on Sertoli cells and JAM3 on germ cells anchor germ cells and support polarity complex assembly during spermatid differentiation.
JAM2 prevents myelination of non-axonal neuronal regions and contributes to myocyte fusion during myogenesis.
JAM2 is a junctional adhesion protein that binds its receptor JAM3 to mediate heterotypic cell-cell interactions. It contributes to leukocyte extravasation, retention of haematopoietic stem and progenitor cells in bone marrow, germ cell anchorage in spermatogenesis and myocyte fusion, and it may play a role in angiogenesis.
JAM2 is also called junctional adhesion molecule B (JAM-B, JAMB), VE-JAM, JAM-2, CD322 and C21orf43. The HGNC full name is junctional adhesion molecule 2. The RefSeq summary notes that alternatively spliced transcript variants have been found for the gene.
A mouse ortholog, Jam2, exists, so the protein can be studied in mouse models. JAM2 belongs to the immunoglobulin superfamily and the JAM family. Check the datasheet of any product for its validated reactivity.
JAM3, the cognate receptor of JAM2, is a related target with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P57087; product specifications from Assay Genie datasheets.